Back
Chugai Pharmaceutical Vs. Nxera Pharma Industry Stock Comparison
Sell
32
CHGCY
Chugai Pharmaceutical
Last Price:
20.30
Seasonality Move:
5.9%
Sell
49
SOLTF
Nxera Pharma
Last Price:
8.05
Seasonality Move:
14.44%
Sell
32
Chugai Pharmaceutical (CHGCY)
is a Sell
Is Chugai Pharmaceutical a Buy, Sell or Hold?
- The current Chugai Pharmaceutical [CHGCY] share price is $20.30. The Score for CHGCY is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- CHGCY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $8.05. The Score for SOLTF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- SOLTF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CHGCY Stock Price Chart
What is Chugai Pharmaceutical's stock price today?
-
The Chugai Pharmaceutical share price today is $20.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CHGCY is experiencing slight buying pressure.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $8.05
The current trend is relatively stagnant and SOLTF is experiencing slight buying pressure.
CHGCY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.81 | Sell |
Relative Strength Index (14 RSI): | 29.17 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.63 - 24.27) | Sell |
Bollinger Bands (100): | (20.76 - 24.44) | Sell |
SOLTF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 52.73 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.37 - 8.05) | Buy |
Bollinger Bands (100): | (7.99 - 10.09) | Sell |
CHGCY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.5 | Sell |
20-day SMA: | 22.94 | Sell |
50-day SMA: | 23.47 | Sell |
200-day SMA: | 20.08 | Buy |
8-day EMA: | 21.33 | Sell |
20-day EMA: | 22.36 | Sell |
50-day EMA: | 22.86 | Sell |
200-day EMA: | 20.61 | Sell |
SOLTF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.05 | Sell |
20-day SMA: | 7.75 | Buy |
50-day SMA: | 8.28 | Sell |
200-day SMA: | 9.4 | Sell |
8-day EMA: | 8.02 | Buy |
20-day EMA: | 7.95 | Buy |
50-day EMA: | 8.25 | Sell |
200-day EMA: | 9.38 | Sell |
Chugai Pharmaceutical Earnings Growth & CHGCY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Chugai Pharmaceutical Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nxera Pharma Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |